Boeing’s Big Bounce Back & Ozempic Maker Loses its Lead

Episode 637: Neal and Toby chat about Boeing’s strongest quarter yet as it seems to have successfully turned the tides of its performance. Then, Novo Nordisk, the maker of Ozempic and Wegovy, are losing the lead to other competitors and copycat drugs. Also, the AI surge is also causing a surge in electricity bills for the locals who live around these massive data centers. Plus, Uggs are becoming popular footwear for men as celebrities help boost sales. Build your Range Rover Sport at RangeRover.com/US/Sport Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app. Listen to Morning Brew Daily Here:⁠ ⁠⁠https://www.swap.fm/l/mbd-note⁠⁠⁠ Watch Morning Brew Daily Here:⁠ ⁠⁠https://www.youtube.com/@MorningBrewDailyShow⁠ 00:00 - Tsunami warning 2:40 - Boeing bounces back 8:20 - Novo Nordisk loses its edge 11:50 - AI is making electric bills higher 17:50 - Uggs, they’re for men too! 21:00 - Sprint Finish!